Accelerate Diagnostics, Inc. (0H8E.L)
USD 0.57
(-14.24%)
USD 0.57
(-14.24%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -50.77 Million USD | 15.1% |
| 2022 | -59.8 Million USD | 13.38% |
| 2021 | -69.04 Million USD | -13.74% |
| 2020 | -60.3 Million USD | 13.56% |
| 2019 | -70.22 Million USD | 9.74% |
| 2018 | -77.8 Million USD | -25.52% |
| 2017 | -61.98 Million USD | 5.14% |
| 2016 | -64.15 Million USD | -49.35% |
| 2015 | -43.75 Million USD | -45.38% |
| 2014 | -30.09 Million USD | -101.51% |
| 2013 | -14.93 Million USD | -105.68% |
| 2012 | -7.26 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -7.72 Million USD | 16.87% |
| 2024 Q1 | -9.29 Million USD | 6.18% |
| 2023 Q3 | -13.83 Million USD | -17.53% |
| 2023 Q1 | -15.26 Million USD | -15.9% |
| 2023 Q2 | -11.77 Million USD | 22.87% |
| 2023 Q4 | -9.91 Million USD | 28.36% |
| 2023 FY | - USD | 15.1% |
| 2022 Q4 | -13.16 Million USD | 7.2% |
| 2022 Q3 | -14.18 Million USD | 17.36% |
| 2022 Q1 | -15.27 Million USD | 18.59% |
| 2022 FY | - USD | 13.38% |
| 2022 Q2 | -17.17 Million USD | -12.38% |
| 2021 Q3 | -13.9 Million USD | 18.21% |
| 2021 FY | - USD | -13.74% |
| 2021 Q1 | -19.36 Million USD | -38.79% |
| 2021 Q4 | -18.76 Million USD | -34.98% |
| 2021 Q2 | -17 Million USD | 12.22% |
| 2020 FY | - USD | 13.56% |
| 2020 Q1 | -16.97 Million USD | 3.17% |
| 2020 Q4 | -13.95 Million USD | 3.53% |
| 2020 Q3 | -14.46 Million USD | 2.97% |
| 2020 Q2 | -14.9 Million USD | 12.17% |
| 2019 Q2 | -17.47 Million USD | 3.95% |
| 2019 FY | - USD | 9.74% |
| 2019 Q4 | -17.53 Million USD | -2.96% |
| 2019 Q3 | -17.02 Million USD | 2.57% |
| 2019 Q1 | -18.19 Million USD | 3.96% |
| 2018 Q2 | -19.87 Million USD | 2.0% |
| 2018 Q1 | -20.28 Million USD | -30.49% |
| 2018 FY | - USD | -25.52% |
| 2018 Q4 | -18.94 Million USD | -1.31% |
| 2018 Q3 | -18.7 Million USD | 5.91% |
| 2017 Q1 | -13.8 Million USD | 10.53% |
| 2017 FY | - USD | 5.14% |
| 2017 Q4 | -15.54 Million USD | 7.27% |
| 2017 Q3 | -16.76 Million USD | -5.55% |
| 2017 Q2 | -15.88 Million USD | -15.06% |
| 2016 Q2 | -17.28 Million USD | -18.15% |
| 2016 Q3 | -16.81 Million USD | 2.7% |
| 2016 FY | - USD | -49.35% |
| 2016 Q4 | -15.42 Million USD | 8.26% |
| 2016 Q1 | -14.62 Million USD | -16.34% |
| 2015 Q2 | -11.86 Million USD | -38.2% |
| 2015 Q3 | -10.73 Million USD | 9.47% |
| 2015 FY | - USD | -45.38% |
| 2015 Q1 | -8.58 Million USD | -7.94% |
| 2015 Q4 | -12.57 Million USD | -17.08% |
| 2014 Q4 | -7.95 Million USD | 7.08% |
| 2014 Q3 | -8.55 Million USD | -7.04% |
| 2014 Q2 | -7.99 Million USD | -42.92% |
| 2014 Q1 | -5.59 Million USD | -10.53% |
| 2014 FY | - USD | -101.51% |
| 2013 Q4 | -5.06 Million USD | -37.04% |
| 2013 FY | - USD | -105.68% |
| 2013 Q2 | -3.68 Million USD | -47.82% |
| 2013 Q1 | -2.49 Million USD | 38.2% |
| 2013 Q3 | -3.69 Million USD | -0.14% |
| 2012 Q4 | -4.03 Million USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| QuidelOrtho Corporation | 545.6 Million USD | 109.306% |